Search

Your search keyword '"Shigeki Watanabe"' showing total 176 results

Search Constraints

Start Over You searched for: Author "Shigeki Watanabe" Remove constraint Author: "Shigeki Watanabe" Search Limiters Full Text Remove constraint Search Limiters: Full Text
176 results on '"Shigeki Watanabe"'

Search Results

1. Synaptotagmin 7 docks synaptic vesicles to support facilitation and Doc2α-triggered asynchronous release

2. Membrane compression by synaptic vesicle exocytosis triggers ultrafast endocytosis

3. Rapid and reversible optogenetic silencing of synaptic transmission by clustering of synaptic vesicles

4. Defunctionalizing intracellular organelles such as mitochondria and peroxisomes with engineered phospholipase A/acyltransferases

5. CaV1 and CaV2 calcium channels mediate the release of distinct pools of synaptic vesicles

6. Nonclinical study and applicability of the absorbed dose conversion method with a single biodistribution measurement for targeted alpha-nuclide therapy

7. The Effect of Roxadustat on Transfusion-Dependent Myelodysplastic Syndrome Complicated by Chronic Kidney Disease

8. Corrosion behavior of iron-chrome alloys in liquid bismuth

9. Asynchronous release sites align with NMDA receptors in mouse hippocampal synapses

10. Synaptotagmin 7 is targeted to the axonal plasma membrane through γ-secretase processing to promote synaptic vesicle docking in mouse hippocampal neurons

11. SynapsEM: Computer-Assisted Synapse Morphometry

12. Re-Evaluations of Zr-DFO Complex Coordination Chemistry for the Estimation of Radiochemical Yields and Chelator-to-Antibody Ratios of 89Zr Immune-PET Tracers

13. Brain-specific Drp1 regulates postsynaptic endocytosis and dendrite formation independently of mitochondrial division

14. Synaptic Vesicle Endocytosis in Different Model Systems

15. Identification of a novel SEPT9-ABL1 fusion gene in a patient with T-cell prolymphocytic leukemia

16. Evaluation of a Wet Chemistry Method for Isolation of Cyclotron Produced [211At]Astatine

17. Flash-and-freeze: coordinating optogenetic stimulation with rapid freezing to visualize membrane dynamics at synapses with millisecond resolution

18. Ultrafast endocytosis at Caenorhabditis elegans neuromuscular junctions

19. AP2 hemicomplexes contribute independently to synaptic vesicle endocytosis

20. UNC-41/stonin functions with AP2 to recycle synaptic vesicles in Caenorhabditis elegans.

21. Opposing activities of LIT-1/NLK and DAF-6/patched-related direct sensory compartment morphogenesis in C. elegans.

22. Open syntaxin docks synaptic vesicles.

23. CaV1 and CaV2 calcium channels mediate the release of distinct pools of synaptic vesicles

26. Comparative evaluation of radionuclide therapy using

27. Absorbed dose simulation of meta-211At-astato-benzylguanidine using pharmacokinetics of 131I-MIBG, and a novel dose conversion method, RAP

28. Transient docking of synaptic vesicles: implications and mechanisms

30. Enhancing the Therapeutic Effect of 2-211At-astato-α-methyl-L-phenylalanine with Probenecid Loading

31. Defunctionalizing intracellular organelles such as mitochondria and peroxisomes with engineered phospholipase A/acyltransferases

32. Defunctionalizing Intracellular Organelles with Genetically-Encoded Molecular Tools Based on Engineered Phospholipase A/Acyltransferases (PLAATs)

33. Synaptotagmin 7 is targeted to the axonal plasma membrane through γ-secretase processing to promote synaptic vesicle docking in mouse hippocampal neurons

34. OSNR Estimation Providing Self-Confidence Level as Auxiliary Output From Neural Networks

35. Dynamin is primed at endocytic sites for ultrafast endocytosis

37. Dynamin is primed at endocytic sites for ultrafast endocytosis

38. Synaptotagmin 7 is enriched at the plasma membrane through γ-secretase processing to promote vesicle docking and control synaptic plasticity in mouse hippocampal neurons

39. Asynchronous release sites align with NMDA receptors in mouse hippocampal synapses

40. Release sites are positioned to activate NMDA receptors

41. Anti-tumor effects and potential therapeutic response biomarkers in α-emitting meta-211At-astato-benzylguanidine therapy for malignant pheochromocytoma explored by RNA-sequencing

42. Axonal transport of Hrs is activity dependent and facilitates synaptic vesicle protein degradation

43. Preclinical evaluation of new α-radionuclide therapy targeting LAT1: 2-[211At]astato-α-methyl-L-phenylalanine in tumor-bearing model

44. Absorbed dose simulation of meta

45. Evaluation of the Cooling Effect by He Gas for the Production of At-211 with a Bi plate

46. Neopentyl glycol as a scaffold to provide radiohalogenated theranostic pairs of high in vivo stability

47. Performance improvement of Compton imaging of astatine-211 by optimising coincidence time windows

49. Improvement and Optimization of Clinically Potent Positron Emitter 76Br Isolation Using the Dry Distillation Approach for its Future Automation

50. Enhancing the therapeutic effect of 2-211At-astato-α-methyl-L-phenylalanine with probenecid loading

Catalog

Books, media, physical & digital resources